---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-22-272491"
form_type: "8-K"
ticker: "ACAD"
cik: "0001070494"
company_name: "ACADIA PHARMACEUTICALS INC"
filed_at: "2022-10-28T23:59:59+00:00"
generated_at: "2026-06-22T22:22:35.938450+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# President Srdjan R. Stankovic to retire Dec 31, 2022; will remain as consultant

## Summary
- Srdjan R. Stankovic notified Acadia of his retirement as President, effective Dec 31, 2022.
- He will continue in his current role through Dec 31 and then serve as consultant and advisor.
- No replacement President has been announced.

## SEC filing metadata
- accession: 0001193125-22-272491
- form_type: 8-K
- ticker: ACAD
- cik: 0001070494
- company_name: ACADIA PHARMACEUTICALS INC
- filed_at: 2022-10-28T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1070494/000119312522272491/0001193125-22-272491-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1070494/000119312522272491/d405912d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-22-272491
- JSON: https://secwatch.observer/filing/0001193125-22-272491.json
- Plain text: https://secwatch.observer/filing/0001193125-22-272491.txt

## Key facts
- Executive change
  Srdjan R. Stankovic departed as President at ACADIA PHARMACEUTICALS INC.
  - Action: retire
  - Role: President
  source text: On October 27, 2022, Srdjan R. Stankovic, M.D., M.S.P.H., notified Acadia Pharmaceuticals Inc. (the “Company”) of his intention to retire as the Company’s President, effective December 31, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1070494/000119312522272491/0001193125-22-272491-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.